p38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1

Author: Nerurkar S. S.   Olzinski A. R.   Frazier K. S.   Mirabile R. C.   O'Brien S. P.   Jing J.   Rajagopalan D.   Yue T. -L.   Willette R. N.  

Publisher: Informa Healthcare

ISSN: 1366-5804

Source: Biomarkers, Vol.12, Iss.1, 2007-01, pp. : 87-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content